Von der Leyen: no mention of biotechnology

Scientists prevent transplant rejection

Draupnir Bio ApS raises further equity

CordenPharma invests €900m in peptide patform expansion

Catalym raises US$150m

Sensorion achieves milestones in Phase II trial

Rentschler doubles cGMP capacity

SciRhom GmbH closes €63m Series A financing

Ligand Pharma to acquire Apeiron Biologics